Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 3031 AL 3045

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

Mattsson N, Blennow K, Zetterberg H.

Clin Chem Lab Med. 2010 May;48(5):603-7. doi: 10.1515/CCLM.2010.131.

Impact of the CD40-CD40L dyad in Alzheimer's disease

Giunta B, Rezai-Zadeh K, Tan J.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):149-55. doi: 10.2174/187152710791012099.

Alzheimer's disease and retinal neurodegeneration

Guo L, Duggan J, Cordeiro MF.

Curr Alzheimer Res. 2010 Feb;7(1):3-14. doi: 10.2174/156720510790274491.

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

Krautwald M, Münch G.

Exp Gerontol. 2010 Oct;45(10):744-51. doi: 10.1016/j.exger.2010.03.001. Epub 2010 Mar 6.

[Diagnosis of Alzheimer's disease]

Derouesné C.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):5-6. doi: 10.1684/pnv.2010.0202.

[What use of biological markers for the diagnosis of Alzheimer's disease and associated disorders?]

Krolak-Salmon P.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):25-31. doi: 10.1684/pnv.2009.0189.

[Importance of molecular diagnostics in Alzheimer dementia. A case report]

Honneth J, Nehen HG, Haseke J.

Z Gerontol Geriatr. 2010 Jun;43(3):177-9. doi: 10.1007/s00391-010-0101-1. Epub 2010 Apr 1.

Cerebrospinal fluid biomarkers of Alzheimer's disease

Fagan AM, Holtzman DM.

Biomark Med. 2010 Feb;4(1):51-63. doi: 10.2217/BMM.09.83.

Aging and lateralization of the rat brain on a biochemical level

Kristofiková Z, Rícný J, Ort M, Rípová D.

Neurochem Res. 2010 Aug;35(8):1138-46. doi: 10.1007/s11064-010-0165-8. Epub 2010 Apr 6.

Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease

Rabinovici GD, Roberson ED.

Ann Neurol. 2010 Mar;67(3):283-5. doi: 10.1002/ana.22020.

Biomarkers of oxidative damage and inflammation in Alzheimer's disease

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89.

Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

Reiman EM, Langbaum JB, Tariot PN.

Biomark Med. 2010 Feb;4(1):3-14. doi: 10.2217/bmm.09.91.

Biomarkers in Alzheimer's disease: past, present and future

Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA.

Biomark Med. 2010 Feb;4(1):15-26. doi: 10.2217/bmm.09.86.

Role of progranulin as a biomarker for Alzheimer's disease

Sleegers K, Brouwers N, Van Broeckhoven C.

Biomark Med. 2010 Feb;4(1):37-50. doi: 10.2217/bmm.09.82.

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

Thambisetty M, Lovestone S.

Biomark Med. 2010 Feb;4(1):65-79. doi: 10.2217/bmm.09.84.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias